These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22492508)

  • 1. Bicyclic peptides with optimized ring size inhibit human plasma kallikrein and its orthologues while sparing paralogous proteases.
    Baeriswyl V; Rapley H; Pollaro L; Stace C; Teufel D; Walker E; Chen S; Winter G; Tite J; Heinis C
    ChemMedChem; 2012 Jul; 7(7):1173-6. PubMed ID: 22492508
    [No Abstract]   [Full Text] [Related]  

  • 2. Bicyclic peptide antagonists derived from genetically encoded combinatorial libraries.
    Heinis C
    Chimia (Aarau); 2011; 65(9):677-9. PubMed ID: 22026178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stable and Long-Lasting, Novel Bicyclic Peptide Plasma Kallikrein Inhibitors for the Treatment of Diabetic Macular Edema.
    Teufel DP; Bennett G; Harrison H; van Rietschoten K; Pavan S; Stace C; Le Floch F; Van Bergen T; Vermassen E; Barbeaux P; Hu TT; Feyen JHM; Vanhove M
    J Med Chem; 2018 Apr; 61(7):2823-2836. PubMed ID: 29517911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bicyclic Peptides as Next-Generation Therapeutics.
    Rhodes CA; Pei D
    Chemistry; 2017 Sep; 23(52):12690-12703. PubMed ID: 28590540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phage selection of cyclic peptide antagonists with increased stability toward intestinal proteases.
    Baeriswyl V; Heinis C
    Protein Eng Des Sel; 2013 Jan; 26(1):81-9. PubMed ID: 23100545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-permeable bicyclic peptide inhibitors against intracellular proteins.
    Lian W; Jiang B; Qian Z; Pei D
    J Am Chem Soc; 2014 Jul; 136(28):9830-3. PubMed ID: 24972263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phage-encoded combinatorial chemical libraries based on bicyclic peptides.
    Heinis C; Rutherford T; Freund S; Winter G
    Nat Chem Biol; 2009 Jul; 5(7):502-7. PubMed ID: 19483697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and development of plasma kallikrein inhibitors for multiple diseases.
    Xie Z; Li Z; Shao Y; Liao C
    Eur J Med Chem; 2020 Mar; 190():112137. PubMed ID: 32066009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of Specific Serine Protease Inhibitors Based on a Versatile Peptide Scaffold: Conversion of a Urokinase Inhibitor to a Plasma Kallikrein Inhibitor.
    Xu P; Xu M; Jiang L; Yang Q; Luo Z; Dauter Z; Huang M; Andreasen PA
    J Med Chem; 2015 Nov; 58(22):8868-76. PubMed ID: 26536069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bicyclization and tethering to albumin yields long-acting peptide antagonists.
    Angelini A; Morales-Sanfrutos J; Diderich P; Chen S; Heinis C
    J Med Chem; 2012 Nov; 55(22):10187-97. PubMed ID: 23088498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New classes of potent and bioavailable human renin inhibitors.
    Remen L; Bezençon O; Richard-Bildstein S; Bur D; Prade L; Corminboeuf O; Boss C; Grisostomi C; Sifferlen T; Strickner P; Hess P; Delahaye S; Treiber A; Weller T; Binkert C; Steiner B; Fischli W
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6762-5. PubMed ID: 19853442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aryl uracil inhibitors of hepatitis C virus NS5B polymerase: synthesis and characterization of analogs with a fused 5,6-bicyclic ring motif.
    Krueger AC; Randolph JT; DeGoey DA; Donner PL; Flentge CA; Hutchinson DK; Liu D; Motter CE; Rockway TW; Wagner R; Beno DW; Koev G; Lim HB; Beyer JM; Mondal R; Liu Y; Kati WM; Longenecker KL; Molla A; Stewart KD; Maring CJ
    Bioorg Med Chem Lett; 2013 Jun; 23(12):3487-90. PubMed ID: 23664214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptides: Bicycling into cells.
    Liskamp RM
    Nat Chem; 2014 Oct; 6(10):855-7. PubMed ID: 25242478
    [No Abstract]   [Full Text] [Related]  

  • 14. Bicyclic peptide inhibitor reveals large contact interface with a protease target.
    Angelini A; Cendron L; Chen S; Touati J; Winter G; Zanotti G; Heinis C
    ACS Chem Biol; 2012 May; 7(5):817-21. PubMed ID: 22304751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seongsanamides A-D: Antiallergic Bicyclic Peptides from Bacillus safensis KCTC 12796BP.
    Kim GJ; Li X; Kim SH; Yang I; Hahn D; Chin J; Nam SJ; Nam JW; Nam DH; Oh DC; Chang HW; Choi H
    Org Lett; 2018 Dec; 20(23):7539-7543. PubMed ID: 30456957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SAR of 4-substituted (6,6-bicyclic) piperidine cathepsin S inhibitors.
    Grice CA; Tays K; Khatuya H; Gustin DJ; Butler CR; Wei J; Sehon CA; Sun S; Gu Y; Jiang W; Thurmond RL; Karlsson L; Edwards JP
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2209-12. PubMed ID: 16458510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SNA-60-367, new peptide enzyme inhibitors against aromatase.
    Kimura K; Nakayama S; Nakamura J; Takada T; Yoshihama M; Esumi Y; Itoh Y; Uramoto M
    J Antibiot (Tokyo); 1997 Jun; 50(6):529-31. PubMed ID: 9268012
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclothialidine analogs, novel DNA gyrase inhibitors.
    Yamaji K; Masubuchi M; Kawahara F; Nakamura Y; Nishio A; Matsukuma S; Fujimori M; Nakada N; Watanabe J; Kamiyama T
    J Antibiot (Tokyo); 1997 May; 50(5):402-11. PubMed ID: 9207910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of [Gly-1]RA-VII, [Gly-2]RA-VII, and [Gly-4]RA-VII. Glycine-containing analogues of RA-VII, an antitumor bicyclic hexapeptide from Rubia plants.
    Hitotsuyanagi Y; Hasuda T; Aihara T; Ishikawa H; Yamaguchi K; Itokawa H; Takeya K
    J Org Chem; 2004 Mar; 69(5):1481-6. PubMed ID: 14987000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological activity of cyclic peptide inhibitors of ribonucleotide reductase.
    Liehr S; Barbosa J; Smith AB; Cooperman BS
    Org Lett; 1999 Oct; 1(8):1201-4. PubMed ID: 10825970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.